HUTCHMED (China) Ltd Files 2024 Annual Report

Ticker: HMDCF · Form: 20-F · Filed: Mar 19, 2025 · CIK: 1648257

Hutchmed (China) LTD 20-F Filing Summary
FieldDetail
CompanyHutchmed (China) LTD (HMDCF)
Form Type20-F
Filed DateMar 19, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: annual-report, pharmaceuticals, sec-filing

TL;DR

HUTCHMED (China) Ltd dropped its 2024 20-F, check financials.

AI Summary

HUTCHMED (China) Ltd filed its 20-F for the fiscal year ending December 31, 2024. The company, previously known as Hutchison China MediTech Ltd, is a pharmaceutical preparations company based in Hong Kong. The filing details its financial performance and business operations for the period.

Why It Matters

This filing provides investors and analysts with a comprehensive overview of HUTCHMED's financial health and strategic direction for 2024, crucial for understanding its performance in the pharmaceutical sector.

Risk Assessment

Risk Level: medium — As a company operating in the pharmaceutical sector, HUTCHMED faces inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of HUTCHMED (China) Ltd?

HUTCHMED (China) Ltd operates in the Pharmaceutical Preparations industry, as indicated by its SIC code 2834.

When was the company's name changed?

The company's name was changed from Hutchison China MediTech Ltd to HUTCHMED (China) Ltd on July 16, 2015.

Where is HUTCHMED (China) Ltd headquartered?

The company's business and mailing address is located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.

What is the SEC file number for this filing?

The SEC file number for this 20-F filing is 001-37710.

What is the accession number for this filing?

The accession number for this filing is 0001410578-25-000377.

Filing Details

This Form 20-F (Form 20-F) was filed with the SEC on March 19, 2025 regarding HUTCHMED (China) Ltd (HMDCF).

View full filing on EDGAR

View Full Filing

View this 20-F filing on SEC EDGAR

View on Read The Filing